Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
News Release
Utah Broadens Physician Dispensing with Exceptions
The Utah Legislature passed HB 301 during the 2022 General Legislative Session.
Workers' Comp
News Release
Enlyte's 2022 Trends Report Offers Strategies to Tackle Big Issues in Auto, Casualty and Workers' Comp
From inflation and regulatory issues to claims automation and the evolving workforce, experts weigh in with unique insight across the P&C l
Workers' Comp
Article
Top 20 Reasons to Consider an Independent Medical Exam
Independent Medical Exams (IMEs) can be a highly effective tool for looking at what is happening on a claim and help provide a strategy for timely
Workers' Comp
Article
When to Place a Referral for Field Case Management
As a claims professional, we recognize you’re encountering new daily challenges. We want you to know that Genex is here to help.
Workers' Comp
Article
What's in Your Medicine Cabinet?
How many of us have medicine cabinets where we store our “you never know” items?
PC 360
Article
The Complex Landscape Surrounding High-Impact Drugs & Workers' Comp
While high costs and other challenges remain a concern, specialty drugs including biologics and biosimilars should be continually evaluated for pot